Literature DB >> 17483066

Epstein-Barr virus infection after unrelated cord blood transplantation: reactivation or reinfection?

Keisei Kawa1, Akihisa Sawada, Maho Koyama, Masami Inoue.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17483066     DOI： 10.1532/IJH97.07014

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  12 in total

Review 1.  Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Authors:  Shinsaku Imashuku
Journal:  Crit Rev Oncol Hematol       Date:  2002-12       Impact factor: 6.312

2.  Epstein-Barr virus early-antigen antibodies before allogeneic haematopoietic stem cell transplantation as a marker of risk of post-transplant lymphoproliferative disorders.

Authors:  Felix Agbalika; Jerome Larghero; Helene Esperou; Dominique Marais; Marie Robin; Elena Foïs; Régis Peffault de Latour; Eliane Gluckman; Vanderson Rocha; Marc Benbunan; Gerard Socié; Jean-Pierre Marolleau
Journal:  Br J Haematol       Date:  2007-01       Impact factor: 6.998

3.  Efficacy of Epstein-Barr virus removal by leukoreduction of red blood cells.

Authors:  Lirong Qu; Shushen Xu; David Rowe; Darrell Triulzi
Journal:  Transfusion       Date:  2005-04       Impact factor: 3.157

4.  Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.

Authors:  Claudio G Brunstein; Daniel J Weisdorf; Todd DeFor; Juliet N Barker; Jakub Tolar; Jo-Anne H van Burik; John E Wagner
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

5.  Successful allogeneic stem cell transplantation from an unrelated donor for aggressive Epstein-Barr virus-associated clonal T-cell proliferation with hemophagocytosis.

Authors:  M Yagita; H Iwakura; T Kishimoto; T Okamura; A Kunitomi; R Tabata; Y Konaka; K Kawa
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

6.  Late-onset fatal Epstein-Barr virus-associated hemophagocytic syndrome following cord blood cell transplantation for adult acute lymphoblastic leukemia.

Authors:  Yoshinari Kawabata; Makoto Hirokawa; Yoshinobu Saitoh; Shigeki Kosugi; Tomoko Yoshioka; Masumi Fujishima; Naohito Fujishima; Yoshihiro Kameoka; Hirobumi Saitoh; Masaaki Kume; Naoto Takahashi; Ken-ichi Sawada
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

7.  Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency.

Authors:  J W Gratama; M A Oosterveer; F E Zwaan; J Lepoutre; G Klein; I Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation?

Authors:  E Meijer; S Spijkers; S Moschatsis; G J Boland; S F T Thijsen; A M van Loon; L F Verdonck
Journal:  Transpl Infect Dis       Date:  2005-03       Impact factor: 2.228

9.  Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

Authors:  C M Rooney; C A Smith; C Y Ng; S K Loftin; J W Sixbey; Y Gan; D K Srivastava; L C Bowman; R A Krance; M K Brenner; H E Heslop
Journal:  Blood       Date:  1998-09-01       Impact factor: 22.113

10.  Detection of multiple Epstein-Barr viral strains in allogeneic bone marrow transplant recipients.

Authors:  J W Gratama; E T Lennette; B Lönnqvist; M A Oosterveer; G Klein; O Ringdén; I Ernberg
Journal:  J Med Virol       Date:  1992-05       Impact factor: 2.327
View more
  1 in total

Review 1.  Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation.

Authors:  Hideaki Ohta; Norihide Fukushima; Keiichi Ozono
Journal:  Int J Hematol       Date:  2009-08-12       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.